Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient.
about
Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trialHyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgeryCorticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database.Disturbance of glucose homeostasis after pediatric cardiac surgeryContinuous glucose monitors prove highly accurate in critically ill children.Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study.U-shaped relationship between early blood glucose and mortality in critically ill children.Tight Glycemic Control With Insulin Does Not Affect Skeletal Muscle Degradation During the Early Postoperative Period Following Pediatric Cardiac Surgery.Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery.Tight glycemic control versus standard care after pediatric cardiac surgery.Relationship between hyperglycemia and outcome in children with severe traumatic brain injury.Prevalence and clinical outcome of inpatient hyperglycemia in a community pediatric hospital.Glycemic control in pediatric patients on extracorporeal membrane oxygenation.Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study.Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.Endocrinal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease.Hyperglycemia in critically ill children.Perioperative management of blood glucose during open heart surgery in infants and children.Critical illness hyperglycemia in pediatric cardiac surgery.Intensive glycemic control after heart transplantation is safe and effective for diabetic and non-diabetic patients.Endocrinopathies in the cardiac ICU.Does tight glycemic control improve outcomes in pediatric patients undergoing surgery and/or those with critical illness?Tight glucose control in critically ill children--a systematic review and meta-analysis.Hyperglycemia and postoperative outcomes in pediatric neurosurgery.Early change in blood glucose concentration is an indicator of mortality in critically ill children.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Results of a Feeding Protocol in Patients Undergoing the Hybrid Procedure.Blood Glucose Variability and Outcomes in Critically Ill Children.Endocrinologic Diseases in Pediatric Cardiac Intensive Care.Remifentanil prevents increases of blood glucose and lactate levels during cardiopulmonary bypass in pediatric cardiac surgery.Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass.Metabolic Uncoupling Following Cardiopulmonary Bypass.Management of perioperative low cardiac output state without extracorporeal life support: What is feasible?Higher glycemic variability in very low birth weight newborns is associated with greater early neonatal mortality.Intraoperative glycemic control without insulin infusion during pediatric cardiac surgery for congenital heart disease.Endogenous glucose production from infancy to adulthood: a non-linear regression model.Hyperglycaemia is negatively associated with systemic and cerebral oxygen transport in neonates after the Norwood procedure.Etiology of hyperglycemia in critically ill children and the impact of organ dysfunction
P2860
Q27003097-696FEFC7-B614-4A93-B1FF-5C2841F0405DQ33707011-46B190C5-E3F9-4519-813C-44C48DD1EE18Q33734163-1E4B89BB-765F-4017-9DFD-A8BBC0DBDE76Q33941003-FD222413-5B97-4BA8-8D74-CC5925F78E01Q34452847-09275ED7-A3E7-458C-873F-0D39EA557F8EQ34551238-A1BE7972-7AAB-473B-8136-9B8C3BB82A7EQ35559218-2FA36A57-3B84-43F1-AE89-72896B82E2CDQ35566940-5AEA415E-4136-4CDC-B221-F67FEE7A0224Q35708706-A77FC04B-E6D0-4616-AD83-1CE1A6E973A0Q35836522-FD9CE5EB-1806-4072-B28F-C2A0F2C7EB64Q36335630-9A1A06FD-CC59-4D63-B54C-8E0F92322B23Q36409992-CEA24363-B4DA-4074-91D7-0AD8BB685C50Q36914290-7CEC6FFC-BEFB-475A-AE9C-29A34FFA0A32Q37011711-8634FCB7-96E2-41EC-85EF-E9887C693E00Q37178381-BC3311CF-88C3-4FA5-88E9-810A44CE4BA9Q37206795-CBE493DA-13C0-453D-9E71-B033B3E69B0AQ37253036-9E1DE227-8E47-4D44-AB1B-4A212067F33AQ37343546-8781DFD6-204C-443F-B6EB-AE2F170D2138Q37551065-B6AD5274-CBEA-40E2-82F0-BFDB428982BBQ37863730-88D3721B-1308-4B27-BCCD-B397F4A2A15FQ37991761-4C61ED19-500F-44D9-846E-FC097397F0B0Q38097925-8B315C88-0654-4112-8429-84F45F9CE232Q38117258-8103E5B4-0454-4E77-A3C0-086E9C14A7FDQ38172500-777803E4-6C8B-4D10-AAD2-142BD6A1E4DEQ38208326-11E01FF9-7D62-42A4-99B8-C330CF734370Q38274386-C87FCCFB-FD3E-40C7-A373-3F8BCCB7A586Q38462043-D21472AC-48BD-4DF3-B33D-A03E3A61E9FFQ38751931-98E834AE-C0D4-4ED2-8BDB-8FF81D89EB56Q38752439-6BB6BD89-AC77-4329-BBF3-6A78DC9EF34AQ38841448-E7692730-2E26-4D04-96D5-857CD905203AQ38918258-1911F0C1-526B-4A36-857A-B800E6A5B39CQ39027689-E2307F03-B12E-4944-A892-B58C05A47838Q39816946-4844F27D-DC57-4882-AEE2-C6859939F5B5Q40300482-951FA09B-65A8-41EC-B63E-AEBB87007993Q41874669-502E44AA-03BD-471A-9726-221FCC055AEBQ47355152-2B30667A-9FF7-430C-AD3C-90ACD392E4CAQ48273995-A3AB318B-5479-4D54-99FE-79DAB9B77A8FQ48293004-09D3EE90-D121-4EFF-A5B5-93B3B6F431CBQ49032224-E5B45437-0386-48DC-B6D3-00109D2FF0D9Q57496608-D7B424E3-69AE-4B64-A473-FC247ADABF65
P2860
Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@ast
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@en
type
label
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@ast
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@en
prefLabel
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@ast
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@en
P2093
P1476
Hyperglycemia is a marker for ...... ive pediatric cardiac patient.
@en
P2093
Andrew R Yates
Clifford L Cua
John Hayes
Peter C Dyke
Roozbeh Taeed
Timothy F Feltes
P304
P356
10.1097/01.PCC.0000227755.96700.98
P577
2006-07-01T00:00:00Z